Structural Biology and Biochemistry of Cytochrome P450 Systems in Mycobacterium tuberculosis

REFERENCES

• Ahmad Z., Sharma S., Khuller G. K. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv. FEMS Microbiol. Lett. 2005; 251: 19–22
   PubMed Web of Science ®Google Scholar
• Ahmad Z., Sharma S., Khuller G. K. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis. FEMS Microbiol. Lett. 2006a; 261: 181–186
   PubMed Web of Science ®Google Scholar
• Ahmad Z., Sharma S., Khuller G. K., Singh P., Faujdar J., Katoch V. M. Antomycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 2006b; 28: 543–544
   PubMed Web of Science ®Google Scholar
• Aoyama Y., Horiuchi T., Gotoh O., Noshiro M., Yoshida Y. CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. J. Biochem. 1998; 124: 694–696
   PubMed Web of Science ®Google Scholar
• Barry C. E., Crick D. C., McNeil M. R. Targeting the formation of the cell wall core of M. tuberculosis. Infect. Disord. Drug Targets 2007; 7: 182–202
   PubMedGoogle Scholar
• Bellamine A., Mangla A. T., Nes W. D., Waterman M. R. Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 1999; 96: 8937–8942
   PubMed Web of Science ®Google Scholar
• Betts J. C., Lukey P. T., Robb L. C., McAdam R. A., Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 2002; 43: 717–731
   PubMed Web of Science ®Google Scholar
• Betts J. C., McLaren A., Lennon M. G., Kelly F. M., Lukey P. T., Blakemore S. J., Duncan K. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimcrob. Agents Chemother. 2003; 47: 2903–2913
   PubMed Web of Science ®Google Scholar
• Bossi R. T., Aliverti A., Raimondi D., Fischer F., Zanetti G., Ferrari D., Tahallah N., Maier C. S., Heck A. J., Rizzi M., Mattevi A. A covalent modification of NADP+ revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. Biochemistry 2002; 41: 8807–8818
   PubMed Web of Science ®Google Scholar
• Brennan P. J., Crick D. C. The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Curr. Top. Med. Chem. 2007; 7: 475–488
   PubMed Web of Science ®Google Scholar
• Brennan P. J., Nikaido H. The envelope of mycobacteria. Annu. Rev. Biochem. 1995; 64: 29–63
   PubMed Web of Science ®Google Scholar
• Brennan P. J., Vissa V. D. Genomic evidence for the retention of the essential mycobacterial cell wall in the otherwise defective. Mycobacterium leprae Lepr Rev, 72: 415–428
   Google Scholar
• Camus J. C., Pryor M. J., Médigue C., Cole S. T. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 2002; 148: 2967–2973
   PubMed Web of Science ®Google Scholar
• Casali N., Riley L. W. A phylogenomic analysis of the Actinomycetales mce operons. BMC Genomics 2007; 8: 60
   PubMed Web of Science ®Google Scholar
• Chang J. C., Harik N. S., Liao R. P., Sherman D. R. Identification of mycobacterial genes that alter growth and pathology in macrophages and in mice. J. Infect. Dis. 2007; 196: 788–795
   PubMed Web of Science ®Google Scholar
• Cole S. T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S. V., Eiglmeier K., Gas S., Barry C. E., 3rd, Tekaia F., Badcock K., Basham D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M. A., Rajandream M. A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J. E., Taylor K., Whitehead S., Barrell B. G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537–544
   PubMed Web of Science ®Google Scholar
• Daffé M., Etienne G. The capsule of Mycobacterium tuberculosis and its implications for pathogenicity. Tuber. Lung Dis. 1999; 79: 153–169
   Google Scholar
• Davydov R., Perera R., Jin S., Yang T. C., Bryson T. A., Sonon M., Dawson J. H., Hoffman B. M. Substrate modulation of the properties and reactivity of the oxy-ferrous and hydroperoxo-ferric intermediates of cytochrome P450cam as shown by cryoreduction-EPR/ENDOR spectroscopy. J. Am. Chem. Soc. 2005; 127: 1403–1413
   PubMed Web of Science ®Google Scholar
• Denisov I. G., Makris T. M., Sligar S. G., Schlichting I. Structure and chemistry of cytochrome P450. Chem. Rev. 2005; 105: 2253–2277
   PubMed Web of Science ®Google Scholar
• Gamieldien J., Ptitsyn A., Hide W. Eukaryotic genes in Mycobacterium tuberculosis could have a role in pathogenesis and immunomodulation. Trends Genet. 2002; 18: 5–8
   PubMed Web of Science ®Google Scholar
• Garnier T., Eiglmeier K., Camus J. C., Medina N., Mansoor H., Pryor M., Duthoy S., Grondin S., Lacroix C., Monsempe C., Simon S., Harris B., Atkin R., Doggett J., Mayes R., Keating L., Wheeler P. R., Parkhill J., Barrell B. G., Cole S. T., Gordon S. V., Hewinson R. G. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. USA 2003; 100: 7877–7882
   PubMed Web of Science ®Google Scholar
• Gordon S. V., Brosch R., Billault A., Garnier T., Eiglmeier K., Cole S. T. Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol. Microbiol. 1999; 32: 643–655
   PubMed Web of Science ®Google Scholar
• Gradmann C. Robert Koch and the white death: from tuberculosis to tuberculin. Microbes Infect. 2006; 8: 294–301
   PubMed Web of Science ®Google Scholar
• Hsu M. H., Savas U., Griffin K. J., Johnson E. F. Human cytochrome P450 family 4 enzymes: function, genetic variation and regulation. Drug Metab. Rev. 2007; 39: 515–538
   PubMed Web of Science ®Google Scholar
• Janin Y. L. Antituberculosis drugs: ten years of research. Bioorg. Med. Chem. 2007; 15: 2479–2513
   PubMed Web of Science ®Google Scholar
• Kaul D., Anand P. K., Verma I. Cholesterol-sensor initiates M. tuberculosis entry into human macrophages. Mol. Cell Biochem. 2004; 258: 219–222
   PubMed Web of Science ®Google Scholar
• Kendall S. L., Rison S. C., Movahedzadeh F., Frita R., Stoker N. G. What do microarrays really tell us about M. tuberculosis?. Trends Microbiol. 2004; 12: 537–544
   PubMed Web of Science ®Google Scholar
• Laurenzi M., Ginsberg A., Spigelman M. Challenges associated with current and future TB treatment. Infect. Disord. Drug Targets 2007; 7: 105–119
   Google Scholar
• Lepesheva G. I., Waterman M. R. Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim. Biophys. Acta 2007; 1770: 467–477
   PubMed Web of Science ®Google Scholar
• Lety M. A., Nair S., Berche P., Escuyer V. A single point mutation in the embB gene is responsible for resistance to ethambutol in Mycobacterium smegmatis. Antimcrob. Agents Chemother. 1997; 41: 2629–2633
   PubMed Web of Science ®Google Scholar
• Leys D., Mowat C. G., McLean K. J., Richmond A., Chapman S. K., Walkinshaw M. D., Munro A. W. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 Å reveals novel features of cytochrome P450. J. Biol. Chem. 2003; 278: 5141–5147
   PubMed Web of Science ®Google Scholar
• McLean K. J., Cheesman M. R., Rivers S. L., Richmond A., Leys D., Chapman S. K., Reid G. A., Price N. C., Kelly S. M., Clarkson J., Smith W. E., Munro A. W. Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from. Mycobacterium tuberculosis. J. Inorg. Biochem. 2002b; 91: 527–541
   PubMed Web of Science ®Google Scholar
• McLean K. J., Clift D., Lewis D. G., Sabri M., Balding P. R., Sutcliffe M. J., Leys D., Munro A. W. The preponderance of P450s in the Mycobacterium tuberculosis genome. Trends Microbiol. 2006b; 14: 220–228
   PubMed Web of Science ®Google Scholar
• McLean K. J., Dunford A. J., Neeli R., Munro A. W. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems. Arch. Biochem. Biophys. 2007; 464: 228–240
   PubMed Web of Science ®Google Scholar
• McLean K. J., Marshall K. R., Richmond A., Hunter I. S., Fowler K., Kieser T., Gurcha S. S., Besra G. S., Munro A. W. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 2002a; 148: 2937–2949
   PubMed Web of Science ®Google Scholar
• McLean K. J., Scrutton N. S., Munro A. W. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA. Biochem. J. 2003; 372: 317–327
   PubMed Web of Science ®Google Scholar
• McLean K. J., Warman A. J., Seward H. E., Marshall K. R., Girvan H. M., Cheesman M. R., Waterman M. R., Munro A. W. Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions. Biochemistry 2006a; 45: 8427–8443
   PubMed Web of Science ®Google Scholar
• Morlock G. P., Metchock B., Sikes D., Crawford J. T., Cooksey R. C. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 2003; 47: 3799–3805
   PubMed Web of Science ®Google Scholar
• Munro A. W., Girvan H. M., McLean K. J. Variations on a (t)heme-novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat. Prod. Rep. 2007a; 24: 585–609
   PubMed Web of Science ®Google Scholar
• Munro A. W., Girva n. H. M., McLean K. J. Cytochrome P450-redox partner fusion enzymes. Biochim. Biophys. Acta 2007b; 1770: 345–359
   PubMed Web of Science ®Google Scholar
• Munro A. W., Leys D. G., McLean K. J., Marshall K. R., Ost T. W., Daff S., Miles C. S., Chapman S. K., Lysek D. A., Moser C. C., Page C. C., Dutton P. L. P450 BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 2002; 27: 250–257
   PubMed Web of Science ®Google Scholar
• Munro A. W., Lindsay J. G. Bacterial cytochromes P-450. Mol. Microbiol. 1996; 20: 1115–1125
   PubMed Web of Science ®Google Scholar
• Neeli R., Sabri M., McLean K. J., Dunford A. J., Scrutton N. S., Leys D., Munro A. W. Tryptophan 359 regulates flavin thermodynamics and coenzyme selectivity in. Mycobacterium tuberculosis FprABiochem. J 2008, (in press)
   Google Scholar
• Nelson D. R. Cytochrome P450 nomenclature, 2004. Methods Mol. Biol. 2004; 320: 1–10
   Google Scholar
• Ogura H., Nishida C. R., Hoch U. R., Perera R., Dawson J. H., Ortiz de Montellano P. R. EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme. Biochemistry 2004; 43: 14712–14721
   PubMed Web of Science ®Google Scholar
• Ouellet H., Podust L. M., Ortiz de Montellano P. R. Mycobacterium tuberculosis CYP130: Crystal structure, biophysical characterization, and interactions with antifungal azole drugs. J. Biol. Chem 2008, in press
   Google Scholar
• Podust L. M., Poulos T. L., Waterman M. R. Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. USA 2001; 98: 3068–3073
   PubMed Web of Science ®Google Scholar
• Podust L. M., Yermalitskaya L. V., Lepesheva G. I., Podust V. N., Dalmasso E. A., Waterman M. R. Estriol bound and ligand-free structures of sterol 14alpha-demethylase. Structure 2004; 12: 1937–1945
   PubMed Web of Science ®Google Scholar
• Recchi C., Sclavi B., Rauzier J., Gicquel B., Reyrat J. M. Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulation. J. Biol. Chem. 2003; 278: 33763–33773
   Google Scholar
• Sassetti C. M., Boyd D. H., Rubin E. J. Comprehensive identification of conditionally essential genes in mycobacteria. Proc. Natl. Acad. Sci. USA 2001; 98: 12712–12717
   PubMed Web of Science ®Google Scholar
• Sassetti C. M., Rubin E. J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci USA 2003; 100: 12989–12994
   PubMed Web of Science ®Google Scholar
• Schnappinger D., Ehrt S., Voskuil M. I., Mangan J. A., Monahan I. M., Dolganov G., Efron B., Butcher P. D., Nathan C., Schoolnik G. K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. J. Exp. Med. 2003; 198: 693–704
   PubMed Web of Science ®Google Scholar
• Seward H. E., Roujeinikova A., McLean K. J., Munro A. W., Leys D. Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode. J. Biol. Chem. 2006; 281: 39437–39443
   PubMed Web of Science ®Google Scholar
• Stewart G. R., Wernisch L., Stabler R., Mangan J. A., Hinds J., Laing K. G., Young D. B., Butcher P. D. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 2002; 148: 3129–3138
   PubMedGoogle Scholar
• Vilchèze C., Jacobs W. R., Jr. The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev. Microbiol. 2007; 61: 35–30
   PubMed Web of Science ®Google Scholar
• Vilchèze C., Wang F., Arai M., Hazbón M. H., Colangeli R., Kremer L., Weisbrod T. R., Alland D., Sacchettini J. C., Jacobs W. R., Jr. Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid. Nat. Med. 2006; 12: 1027–1029
   PubMed Web of Science ®Google Scholar
• http://www.who.int/tb/publications/1994/en/index.html, WHO publication no. WHO/TB/94.177 (1994). TB: A global emergency, WHO report on the TB epidemic, 1994. Published by the World Health Organization
   Google Scholar
• Van der Geize R., Yam K., Heuser T., Wilbrink M. H., Hara H., Anderton M. C., Sim E., Dijkhuizen L., Davies J. E., Mohn W. W., Eltis L. D. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc. Natl. Acad. Sci. USA 2007; 104: 1947–1952
   PubMed Web of Science ®Google Scholar
• Vergne I., Chua J., Singh S. B., Deretic V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Develop. Biol. 2004; 20: 367–394
   PubMed Web of Science ®Google Scholar
• Waterman M. R., Lepesheva G. I. Sterol 14a-demethylase, an abundant and essential mixed-function oxidase. Biochem. Biophys. Res. Commun. 2005; 338: 418–422
   PubMed Web of Science ®Google Scholar
• Zanno A., Kwiatkowski N., Vaz A. D., Guardiola-Diaz H. M. MT FdR: a ferredoxin reductase from M. tuberculosis that couples to MT CYP51. Biochim. Biophys Acta 2005; 1707: 157–169
   PubMed Web of Science ®Google Scholar
• Zhao X., Yu H., Yu S., Wang F., Sacchettini J. C., Magliozzo R. S. Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry 2006; 45: 4131–4140
   PubMed Web of Science ®Google Scholar